Introducing the Parsortix®PC1 system - the first medical device to receive FDA clearance for the harvest of intact CTCs
Enabling specialised circulating tumour cell (CTC) enrichment and downstream analysis within your laboratory
Our laboratory provides specialized circulating tumor cell (CTC) enrichment and analysis services
Latest report
Please click the links below to download our Annual and Interim Reports and Financial Statements
For any investor relations queries please contact